Internal Medicine, Gastroenterology · Springfield, MO
NPI
1356721138
Since 2015
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3901 S Fremont Ave Fl 4
Springfield, MO, 65804
Phone (417) 875-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
765 services
Medicare patients, 2024
348
Average age 71
Drug cost, 2024
$273K
1,372 prescriptions
Company payments, 2025
$621
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravinder Mankoo was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 165 times for 161 patients. In total Ravinder Mankoo billed 765 services in 60 codes, and Medicare paid $61K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 165 | 161 | $3.43 | $566 |
| 45385 Colonoscopy - Lesion Removal | Office | 89 | 88 | $191.89 | $17K |
| 45380 Lower GI Endoscopy - Other | Office | 52 | 52 | $69.14 | $3,595 |
| 43239 Upper GI Endoscopy | Office | 52 | 49 | $66.40 | $3,453 |
| 99213 Office E&M - Established | Office | 49 | 37 | $58.46 | $2,864 |
| 91110 Standard X-ray | Office | 30 | 30 | $79.88 | $2,396 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 28 | 28 | $2.91 | $81.43 |
| 43239 Upper GI Endoscopy | Facility | 27 | 26 | $47.73 | $1,289 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 20 | 20 | $169.98 | $3,400 |
| 45385 Colonoscopy - Lesion Removal | Facility | 17 | 17 | $158.01 | $2,686 |
| 43249 Upper GI Endoscopy | Office | 17 | 16 | $94.25 | $1,602 |
| 43259 Upper GI Endoscopy | Facility | 16 | 16 | $145.08 | $2,321 |
| 45380 Lower GI Endoscopy - Other | Facility | 14 | 14 | $69.83 | $978 |
| 43242 Upper GI Endoscopy | Facility | 12 | 12 | $153.38 | $1,841 |
By year: 2022 $38K for 482 services; 2023 $60K for 770 services; 2024 $61K for 765 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ravinder Mankoo prescribed most often to Medicare patients was Metoclopramide Hcl, with 497 prescriptions and refills. In total Ravinder Mankoo wrote 1,372 Medicare prescriptions that cost $273K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoclopramide Hcl Generic | 497 | 497 | 463 | $295 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 369 | 376 | 350 | $7,227 |
| Pantoprazole Sodium Generic | 122 | 288 | 50 | $1,348 |
| Omeprazole Generic | 90 | 200 | 36 | $923 |
| Gavilyte-N Sodium Chloride/Nahco3/Kcl/Peg | 60 | 60 | 58 | $770 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 38 | 38 | 37 | $642 |
| Creon Lipase/Protease/Amylase | 16 | 21 | Under 11 | $41K |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 15 | 15 | 14 | $1,147 |
| Mesalamine Generic | 14 | 35 | Under 11 | $8,995 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 12 | 12 | Under 11 | $239 |
| Famotidine Generic | 12 | 28 | Under 11 | $61.94 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 11 | 11 | 11 | $181 |
Brand drugs: - claims; generic drugs: 1,166 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravinder Mankoo $621 ($621 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $168.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $168 |
| Gilead Sciences, Inc. GILD | 4 | $88.67 |
| Lilly USA, LLC LLY | 3 | $75.97 |
| Janssen Biotech, Inc. JNJ | 3 | $71.2 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $70.99 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $69.26 |
| Madrigal Pharmaceuticals MDGL | 2 | $38.4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $20.33 |
| Intercept Pharmaceuticals, Inc. | 1 | $17.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.